The Patent Finder

SSV Therapeutics, Inc.

Also on record
Records under this name other than the patents SSV Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 5 of 5 · Back to SSV Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,777,071Production of carnitine conjugate intermediates
Lapsed on the fee record
Ended Aug 17, 2018 · USPTO record
Lapsed on the fee recordEnded Aug 17, 2018USPTO record
US 7,718,696Methods of treating diabetes using carnitine conjugates as dual prodrugs
Lapsed on the fee record
Ended May 18, 2018 · USPTO record
Lapsed on the fee recordEnded May 18, 2018USPTO record
US 7,345,190Carnitine conjugates as dual prodrugs and uses thereof
Lapsed on the fee record
Ended Mar 18, 2016 · USPTO record
Lapsed on the fee recordEnded Mar 18, 2016USPTO record
US 8,049,038Carnitine conjugates of adamantanamines derivatives as dual prodrugs for various uses
Lapsed on the fee record
Ended Nov 1, 2015 · USPTO record
Lapsed on the fee recordEnded Nov 1, 2015USPTO record
US 7,977,511Carnitine conjugates of adamantanamines and neramexane derivatives as dual prodrugs for various uses
Lapsed on the fee record
Ended Jul 12, 2015 · USPTO record
Lapsed on the fee recordEnded Jul 12, 2015USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited